SLC19A1 antibody - N-terminal region (ARP44167_T100)

Name SLC19A1 antibody - N-terminal region (ARP44167_T100)
Supplier Aviva Systems Biology
Catalog ARP44167_T100
Prices $229.00
Sizes 100 µl
Host Rabbit
Clonality Polyclonal
Applications IHC WB
Species Reactivities Human
Antigen The immunogen is a synthetic peptide directed towards the N terminal region of human SLC19A1
Purity/Format Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
Description Rabbit Polyclonal
Gene SLC19A1
Supplier Page Shop

Product images

This product has images. Please go to Supplier's page for details.

Product References

Pralatrexate is synergistic with the proteasome inhibitor bortezomib in in vitro - Pralatrexate is synergistic with the proteasome inhibitor bortezomib in in vitro

Marchi E, Paoluzzi L, Scotto L, Seshan VE, Zain JM, Zinzani PL, O'Connor OA. Clin Cancer Res. 2010 Jul 15;16(14):3648-58.

The antiepileptic drugs phenobarbital and carbamazepine reduce transport of - The antiepileptic drugs phenobarbital and carbamazepine reduce transport of

Halwachs S, Lakoma C, Schafer I, Seibel P, Honscha W. Mol Pharmacol. 2011 Oct;80(4):621-9.